Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.37 USD | +0.80% | +0.48% | +25.35% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.35% | 10.12B | |
+25.89% | 661B | |
+26.77% | 566B | |
-6.68% | 352B | |
+20.41% | 332B | |
+2.62% | 283B | |
+13.40% | 231B | |
+4.75% | 200B | |
-9.33% | 195B | |
-5.27% | 145B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Barclays Cuts Price Target on Catalent to $50 From $55, Maintains Equalweight Rating